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SUPPLEMENTARY FIGURES
Supplementary Figure 1: Model performance on simulated distances A) MEDICC2 overestimates distances in sequences where WGD events have occurred if
using the MED without taking WGD events into account. B) Euclidean distance is unable to recover the actual tree distance, especially if WGD events have occured.
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Supplementary Figure 2: Model performance on simulated trees. A) Results of the tree reconstruction for a range of intermediate tree sizes, reaction rates and
WGD rates. B) Results for the phylogenetic tree reconstruction method MEDALT which creates minimum-spanning trees and therefore performs poorly on the simulated
trees. C) MEDICC2 outperforms all other methods also for two other, widely-used tree distance measures; the Quartet distance and the Robinson-Foulds distance.
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Supplementary Figure 3: Overview of the PCAWG cohort. A) MEDICC2 MED-WGD for all PCAWG tumours show differing levels of copy-number evolution.
B) MEDICC2 WGD score for all PCAWG tumours and C) Fraction of samples exhibiting WGD shows varying degrees of WGD events across the cohort.
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Supplementary Figure 4: Evolutionary history of tumour subclones from patient ”A10”.
Supplementary Figure 5: Evolutionary history of tumour subclones from patient “A12”.
Supplementary Figure 6: Evolutionary history of tumour subclones from patient “A17”.
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Supplementary Figure 7: Evolutionary history of tumour subclones from patient “A21”.
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Supplementary Figure 8: Evolutionary history of tumour subclones from patient “A22”.
Supplementary Figure 9: Evolutionary history of tumour subclones from patient “A24”.
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Supplementary Figure 10: Evolutionary history of tumour subclones from patient “A29”.
Supplementary Figure 11: Evolutionary history of tumour subclones from patient “A32”.
Supplementary Figure 12: Evolutionary history of tumour subclones from patient “A34”.
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Supplementary Figure 13: Single-cell cohort from Minussi et al. 2021 A) Inferred phylogeny and allele-specific copy-number profiles for patient TN1 from
Minussi et al. 2021. Superclones and subclones are marked as in the original publication. B) and C) show the inferred phylogenies using the manhattan-distance based
minimum evolution tree as described in the original publication. Unlike the MEDICC2 trees, the Manhattan trees do not recover the super- and subclone structure.
9
